Artal Group’s Kyverna Therapeutics KYTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-200,000	Closed	-$1.5M	–	98
2024 Q2	$1.5M	Hold	200,000	–	–	0.04%	80
2024 Q1	$4.97M	Buy	+200,000	New	+$4.97M	0.13%	62